Literature DB >> 17656088

Identification and characterization of 3-substituted pyrazolyl esters as alternate substrates for cathepsin B: the confounding effects of DTT and cysteine in biological assays.

Michael C Myers1, Andrew D Napper, Nuzhat Motlekar, Parag P Shah, Chun-Hao Chiu, Mary Pat Beavers, Scott L Diamond, Donna M Huryn, Amos B Smith.   

Abstract

Substituted pyrazole esters were identified as hits in a high throughput screen (HTS) of the NIH Molecular Libraries Small Molecule Repository (MLSMR) to identify inhibitors of the enzyme cathepsin B. Members of this class, along with functional group analogs, were synthesized in an effort to define the structural requirements for activity. Analog characterization was hampered by the need to include a reducing agent such as dithiothreitol (DTT) or cysteine in the assay, highlighting the caution required in interpreting biological data gathered in the presence of such nucleophiles. Despite the confounding effects of DTT and cysteine, our studies demonstrate that the pyrazole 1 acts as alternate substrate for cathepsin B, rather than as an inhibitor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17656088      PMCID: PMC2041802          DOI: 10.1016/j.bmcl.2007.06.091

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  16 in total

Review 1.  The lysosomal cysteine proteases.

Authors:  M E McGrath
Journal:  Annu Rev Biophys Biomol Struct       Date:  1999

2.  An assay for oxidant regulation of protein tyrosine phosphatase activity.

Authors:  Sheng Li; A Richard Whorton
Journal:  Anal Biochem       Date:  2002-04-15       Impact factor: 3.365

Review 3.  Recent advances in the synthesis, design and selection of cysteine protease inhibitors.

Authors:  Alejandro Alvarez Hernandez; William R Roush
Journal:  Curr Opin Chem Biol       Date:  2002-08       Impact factor: 8.822

Review 4.  Inhibitors of cathepsin B.

Authors:  R Frlan; S Gobec
Journal:  Curr Med Chem       Date:  2006       Impact factor: 4.530

Review 5.  Current problems in mechanistic studies of serine and cysteine proteinases.

Authors:  L Polgár; P Halász
Journal:  Biochem J       Date:  1982-10-01       Impact factor: 3.857

6.  Inhibition of cathepsin B reduces beta-amyloid production in regulated secretory vesicles of neuronal chromaffin cells: evidence for cathepsin B as a candidate beta-secretase of Alzheimer's disease.

Authors:  Vivian Hook; Thomas Toneff; Matthew Bogyo; Doron Greenbaum; Katalin F Medzihradszky; John Neveu; William Lane; Gregory Hook; Terry Reisine
Journal:  Biol Chem       Date:  2005-09       Impact factor: 3.915

7.  4-Substituted D-glutamic acid analogues: the first potent inhibitors of glutamate racemase (MurI) enzyme with antibacterial activity.

Authors:  Alfonso de Dios; Lourdes Prieto; Jose Alfredo Martín; Almudena Rubio; Jesus Ezquerra; Mark Tebbe; Beatriz López de Uralde; Justina Martín; Ana Sánchez; Deborah L LeTourneau; James E McGee; Carole Boylan; Thomas R Parr; Michele C Smith
Journal:  J Med Chem       Date:  2002-09-26       Impact factor: 7.446

8.  Catalytic inactivation of protein tyrosine phosphatase CD45 and protein tyrosine phosphatase 1B by polyaromatic quinones.

Authors:  Qingping Wang; Daniel Dubé; Richard W Friesen; Tammy G LeRiche; Kevin P Bateman; Laird Trimble; Joe Sanghara; Rebecca Pollex; Chidambaram Ramachandran; Michael J Gresser; Zheng Huang
Journal:  Biochemistry       Date:  2004-04-13       Impact factor: 3.162

9.  Steady state kinetic evidence for an acyl-enzyme intermediate in reactions catalyzed by bovine spleen cathepsin B.

Authors:  A S Bajkowski; A Frankfater
Journal:  J Biol Chem       Date:  1983-02-10       Impact factor: 5.157

10.  Mechanism of action of pyridazine analogues on protein tyrosine phosphatase 1B (PTP1B).

Authors:  Agneta Tjernberg; Dan Hallén; Johan Schultz; Stephen James; Kurt Benkestock; Styrbjörn Byström; Johan Weigelt
Journal:  Bioorg Med Chem Lett       Date:  2004-02-23       Impact factor: 2.823

View more
  11 in total

1.  Design, synthesis, and evaluation of inhibitors of cathepsin L: Exploiting a unique thiocarbazate chemotype.

Authors:  Michael C Myers; Parag P Shah; Mary Pat Beavers; Andrew D Napper; Scott L Diamond; Amos B Smith; Donna M Huryn
Journal:  Bioorg Med Chem Lett       Date:  2008-05-01       Impact factor: 2.823

2.  Covalent Antiviral Agents.

Authors:  Sako Mirzaie; Fatemeh Abdi; Amin GhavamiNejad; Brian Lu; Xiao Yu Wu
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Multi-conformation 3D QSAR study of benzenesulfonyl-pyrazol-ester compounds and their analogs as cathepsin B inhibitors.

Authors:  Zhigang Zhou; Yanli Wang; Stephen H Bryant
Journal:  J Mol Graph Model       Date:  2011-07-07       Impact factor: 2.518

4.  Structure-activity relationship and improved hydrolytic stability of pyrazole derivatives that are allosteric inhibitors of West Nile Virus NS2B-NS3 proteinase.

Authors:  Shyama Sidique; Sergey A Shiryaev; Boris I Ratnikov; Ananda Herath; Ying Su; Alex Y Strongin; Nicholas D P Cosford
Journal:  Bioorg Med Chem Lett       Date:  2009-08-03       Impact factor: 2.823

5.  Identification and synthesis of a unique thiocarbazate cathepsin L inhibitor.

Authors:  Michael C Myers; Parag P Shah; Scott L Diamond; Donna M Huryn; Amos B Smith
Journal:  Bioorg Med Chem Lett       Date:  2007-11-01       Impact factor: 2.823

6.  Evaluation of an orthogonal pooling strategy for rapid high-throughput screening of proteases.

Authors:  Nuzhat Motlekar; Scott L Diamond; Andrew D Napper
Journal:  Assay Drug Dev Technol       Date:  2008-06       Impact factor: 1.738

Review 7.  The identification, characterization and optimization of small molecule probes of cysteine proteases: experiences of the Penn Center for Molecular Discovery with cathepsin B and cathepsin L.

Authors:  Donna M Huryn; Amos B Smith
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

8.  QSAR models for predicting cathepsin B inhibition by small molecules--continuous and binary QSAR models to classify cathepsin B inhibition activities of small molecules.

Authors:  Zhigang Zhou; Yanli Wang; Stephen H Bryant
Journal:  J Mol Graph Model       Date:  2010-02-01       Impact factor: 2.518

9.  Synthesis, characterization, and antimicrobial evaluation of novel 5-benzoyl-N-substituted amino- and 5-benzoyl-N-sulfonylamino-4-alkylsulfanyl-2-pyridones.

Authors:  Galal Elgemeie; Farag Altalbawy; Mohammed Alfaidi; Rania Azab; Atef Hassan
Journal:  Drug Des Devel Ther       Date:  2017-11-28       Impact factor: 4.162

10.  Identification of covalent active site inhibitors of dengue virus protease.

Authors:  Xiaoying Koh-Stenta; Joma Joy; Si Fang Wang; Perlyn Zekui Kwek; John Liang Kuan Wee; Kah Fei Wan; Shovanlal Gayen; Angela Shuyi Chen; CongBao Kang; May Ann Lee; Anders Poulsen; Subhash G Vasudevan; Jeffrey Hill; Kassoum Nacro
Journal:  Drug Des Devel Ther       Date:  2015-12-10       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.